Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nahdia Afiifah Abdul Jalil"'
Publikováno v:
Antioxidants, Vol 12, Iss 12, p 2109 (2023)
Cervical cancer is a prevalent and often devastating disease affecting women worldwide. Traditional treatment modalities such as surgery, chemotherapy, and radiation therapy have significantly improved survival rates, but they are often accompanied b
Externí odkaz:
https://doaj.org/article/93e34f1622394914a5c4beed640d713f
Autor:
Syarifah Aisyah Syed Abd Halim, Norhashima Abd Rashid, Choy Ker Woon, Nahdia Afiifah Abdul Jalil
Publikováno v:
Pharmaceuticals, Vol 16, Iss 5, p 739 (2023)
This scoping review aimed to summarize the effects of natural products targeting phosphoinositide-3-kinases/serine/threonine kinase (PI3K/AKT) in myocardial ischemia-reperfusion injury (MIRI). The review details various types of natural compounds suc
Externí odkaz:
https://doaj.org/article/3ac165c5d5a040e0ad537efa81e0766b
Autor:
Norhashima Abd Rashid, Siti Nur Farhana Mohammed, Syarifah Aisyah Syed Abd Halim, Norzana Abd Ghafar, Nahdia Afiifah Abdul Jalil
Publikováno v:
Pharmaceuticals, Vol 15, Iss 11, p 1419 (2022)
Honey and propolis have recently become the key target of attention for treating certain diseases and promoting overall health and well-being. A high content of flavonoids and phenolic acids found in both honey and propolis contributes to the antioxi
Externí odkaz:
https://doaj.org/article/379209d89e104239840eaabb5b470c60
Publikováno v:
Asian Biomedicine. 15:199-212
The corneal epithelium (CE) forms the outermost layer of the cornea. Despite its thickness of only 50 μm, the CE plays a key role as an initial barrier against any insults to the eye and contributes to the light refraction onto the retina required f
Autor:
Seong Lin Teoh, Nahdia Afiifah Abdul Jalil, Nurul Raudzah Adib Ridzuan, Syarifah Aisyah Syed Abd Halim, Siti Balkis Budin, Farida Hussan, Norhashima Abd Rashid
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 144, Iss, Pp 112328-(2021)
Cisplatin is a potent platinum-based anticancer drug approved by the Food Drug Administration (FDA) in 1978. Despite its advantages against solid tumors, cisplatin confers toxicity to various tissues that limit its clinical uses. In cisplatin-induced